Haemonetics Corp (NYSE:HAE)
| 83.50 Delayed Data As of Sep 23 |  -1.00 / -1.18%Today’s Change | 63.41 Today|||52-Week Range 130.75 | -27.33% Year-to-Date |
Latest HAE News | Press Releases
No recent news for Haemonetics Corp.
Today’s Trading
| Previous close | 84.50 |
| Today’s open | 84.50 |
| Day’s range | 82.87 - 85.69 |
| Volume | 348,997 |
| Average volume (3 months) | 662,984 |
| Market cap | $4.2B |
Data as of 4:00pm ET, 09/23/2020
Growth & Valuation
| Earnings growth (last year) | +41.40% |
| Earnings growth (this year) | -25.61% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +2.16% |
| P/E ratio | 44.9 |
| Price/Sales | 5.29 |
| Price/Book | 7.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ICUIICU Medical Inc | -3.81 | -2.01% |
| IARTIntegra Lifesciences... | -0.31 | -0.68% |
| ---- | ||
| NUVANuVasive Inc | -1.99 | -3.90% |
Data as of 4:00pm ET, 09/23/2020
Financials
| Next reporting date | November 9, 2020 |
| EPS forecast (this quarter) | $0.51 |
| Annual revenue (last year) | $988.5M |
| Annual profit (last year) | $76.5M |
| Net profit margin | 7.74% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
